<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Document</title>
</head>
<body>
  <h1>第 2 节这是一节生物课</h1>
  <p>上节课我们讲了新冠疫苗接种的三原则<span class=" fw-cl "><span>，</span></span>这三个原则帮助你打疫苗是足够了<span class=" fw-cl "><span>，</span></span>但如果要理解新冠疫苗的投资机会<span class=" fw-cl "><span>，</span></span>是远远不够的<span class=" fw-cl "><span>，</span></span>大家必须要对一些基本的医学常识有所理解<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>一说到医药<span class=" fw-cl "><span>，</span></span>许多人马上就懵了<span class=" fw-cl "><span>。</span></span>一直以来<span class=" fw-cl "><span>，</span></span>大家对于医药行业有两个共识<span class=" fw-cl "><span>：</span></span></p>
<p>第一<span class=" fw-cl "><span>，</span></span>医药行业出牛股<span class=" fw-cl "><span>，</span></span>一涨很多倍<span class=" fw-cl "><span>。</span></span></p>
<p>第二<span class=" fw-cl "><span>，</span></span>医药行业研究门槛很高<span class=" fw-cl "><span>，</span></span>如同天书<span class=" fw-cl "><span>。</span></span>所以医药行业的牛股一般人把握不住<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>真是这样吗<span class=" fw-cl "><span>？</span></span>&nbsp;</p>
<p><strong>实际上<span class=" fw-cl "><span>，</span></span>医药行业的确存在一定的研究门槛<span class=" fw-cl "><span>，</span></span>但并不像大家想的那样高不可攀<span class=" fw-cl "><span>。</span></span></strong></p>
<p>大部分人看到医药相关内容就绕路走<span class=" fw-cl "><span>，</span></span>就像翻开一本书只看了序言就合上了<span class=" fw-cl "><span>，</span></span>又怎么能品评内容的难易呢<span class=" fw-cl "><span>？</span></span>&nbsp;</p>
<p>事实上呢<span class=" fw-cl "><span>，</span></span>有很多不是医药相关专业出身的投资人<span class=" fw-cl "><span>，</span></span>也在医药行业上赚到了大钱<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>他们又是怎么做到的呢<span class=" fw-cl "><span>？</span></span>&nbsp;</p>
<p>其实无非是多学多问而已<span class=" fw-cl "><span>。</span></span>所谓多学<span class=" fw-cl "><span>，</span></span>学的是基础知识<span class=" fw-cl "><span>，</span></span>而多问<span class=" fw-cl "><span>，</span></span>问的是专业人士<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p><strong>大部分的投资者都不懂医药<span class=" fw-cl "><span>，</span></span>这其实对于你来说是一件好事<span class=" fw-cl "><span>，</span></span>因为只要你懂一些基础知识<span class=" fw-cl "><span>，</span></span>就能产生超额认知<span class=" fw-cl "><span>，</span></span>也就能有超额收益<span class=" fw-cl "><span>。</span></span></strong></p>
<p>还有更关键的一点<span class=" fw-cl "><span>，</span></span>医药股尤其是创新药的投资<span class=" fw-cl "><span>，</span></span>其实是比较特殊的<span class=" fw-cl "><span>，</span></span>就像上一课说的<span class=" fw-cl "><span>，</span></span>产品线和核心技术平台才是重中之重<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>在纳斯达克<span class=" fw-cl "><span>，</span></span>有很多初创的生物科技公司<span class=" fw-cl "><span>，</span></span>连收入都没有<span class=" fw-cl "><span>，</span></span>只有一两个在研的药物<span class=" fw-cl "><span>，</span></span>每年花掉几千万美元的研发费用<span class=" fw-cl "><span>，</span></span>市值也很小<span class=" fw-cl "><span>。</span></span>然而一旦药物研发有什么突破性进展<span class=" fw-cl "><span>，</span></span>投资者就如同中了彩票<span class=" fw-cl "><span>。</span></span></p>
<p>对于这样的公司<span class=" fw-cl "><span>，</span></span>什么财务报表<span class=" fw-cl "><span>，</span></span>公司治理都是次要的<span class=" fw-cl "><span>，</span></span>最核心的是彩票到底是中了头奖还是谢谢参与<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>这次新冠疫情也是一样<span class=" fw-cl "><span>，</span></span>你不需要理解无数个小问题<span class=" fw-cl "><span>，</span></span>比如各种疫苗的技术细节<span class=" fw-cl "><span>，</span></span>你只要搞清楚一个大问题<span class=" fw-cl "><span>，</span></span>疫情到底是一场闪击战还是一场持久战<span class=" fw-cl "><span>？</span></span></p>
<p>只要你有这个超额认知<span class=" fw-cl "><span>，</span></span>那么你就能超越其他投资人<span class=" fw-cl "><span>，</span></span>甚至很多机构投资人<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>所以我们今天补这节生物课<span class=" fw-cl "><span>。</span></span>主要讲一下新冠疫苗的四种研发路径<span class=" fw-cl "><span>，</span></span>这对于大家理解新冠疫苗行业至关重要<span class=" fw-cl "><span>。</span></span></p>
<p><strong>只有了解了这些<span class=" fw-cl "><span>，</span></span>你才能明白新冠疫苗对于全球疫苗行业产生了何等颠覆性的影响<span class=" fw-cl "><span>，</span></span>而谁又能从这次疫情中<span class=" fw-cl "><span>，</span></span>获得一飞冲天的机会<span class=" fw-cl "><span>，</span></span>有望成长为全球疫苗行业的新龙头<span class=" fw-cl "><span>。</span></span>&nbsp;</strong></p>
<p>在学习新冠疫苗的研发路径之前<span class=" fw-cl "><span>，</span></span>我们先要回顾一下高中生物的一个知识点<span class=" fw-cl "><span>，</span></span>就是<span class="fw-op  "><span>「</span></span>中心法则<span class=" fw-cl fw--collapsed"><span>」</span></span><span class=" fw-cl "><span>。</span></span></p>
<p>简单说就是双螺旋结构的 DNA<span class="fw-op  "><span>（</span></span>脱氧核糖核酸<span class=" fw-cl "><span>）</span></span>转录成单链的 RNA<span class="fw-op  "><span>（</span></span>核糖核酸<span class=" fw-cl fw--collapsed"><span>）</span></span><span class=" fw-cl "><span>，</span></span>RNA 翻译成蛋白质<span class=" fw-cl "><span>。</span></span></p>
<p>而这一年里爆火的 mRNA<span class=" fw-cl "><span>，</span></span>中文名叫信使核糖核酸<span class=" fw-cl "><span>，</span></span>就是 DNA 到蛋白质中间的信使<span class=" fw-cl "><span>，</span></span>主要的工作就是被翻译成蛋白质<span class=" fw-cl "><span>，</span></span>既是信使也是信<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>但新冠病毒是一种 RNA 病毒<span class=" fw-cl "><span>，</span></span>它的遗传信息不是 DNA 而是 RNA<span class=" fw-cl "><span>，</span></span>就是一张单链的小纸条<span class=" fw-cl "><span>。</span></span>这张小纸条被包裹在蛋白外壳里<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>大家可以看到这个蛋白外壳上面有很多皇冠一样的刺突<span class=" fw-cl "><span>，</span></span>这就是刺突蛋白<span class="fw-op  "><span>（</span></span>Spike<span class=" fw-cl fw--collapsed"><span>）</span></span><span class=" fw-cl "><span>，</span></span>称为 S 蛋白<span class=" fw-cl "><span>，</span></span>也正因为这些刺突看起来像皇冠<span class=" fw-cl "><span>，</span></span>这一类病毒才被叫做冠状病毒<span class=" fw-cl "><span>。</span></span></p>
<figure class="central"><img data-src="https://pica.zhimg.com/v2-eef93c6fd85d14dfe936f05f29f44147.png?source=6a64a727" alt="" class="richText-img-source"><span class="processImgLazyload-placeholder-e5egJ richText-img-placeholder" style="padding:30.968169761273213% 0" data-src="https://pica.zhimg.com/v2-eef93c6fd85d14dfe936f05f29f44147.png?source=6a64a727">加载中...</span></figure>
<p>那新冠病毒是怎么感染人体的呢<span class=" fw-cl "><span>？</span></span></p>
<p>我们打一个比方<span class=" fw-cl "><span>，</span></span>S 蛋白就是新冠病毒<span class="fw-op  "><span>（</span></span>SARS- CoV-2<span class=" fw-cl "><span>）</span></span>的手<span class=" fw-cl "><span>，</span></span>而这只手的食指 RBD 结构域恰好可以打开细胞的指纹锁 ACE2<span class=" fw-cl "><span>。</span></span>而病毒进入细胞后<span class=" fw-cl "><span>，</span></span>会把受到感染的细胞变成制造病毒的<span class="fw-op  "><span>「</span></span>细胞工厂<span class=" fw-cl fw--collapsed"><span>」</span></span><span class=" fw-cl "><span>，</span></span>制造大量的新冠病毒<span class=" fw-cl "><span>。</span></span></p>
<p>如果这个被感染的人呢<span class=" fw-cl "><span>，</span></span>没有接种过新冠疫苗<span class=" fw-cl "><span>，</span></span>体内没有抗体<span class=" fw-cl "><span>，</span></span>那么等到免疫系统发现新冠病毒的时候<span class=" fw-cl "><span>，</span></span>这些叛军就已经成了气候<span class=" fw-cl "><span>，</span></span>打起来少不得要折腾一阵<span class=" fw-cl "><span>。</span></span>如果免疫系统不给力或者有其它慢性疾病<span class=" fw-cl "><span>，</span></span>弄不好还会一败涂地<span class=" fw-cl "><span>。</span></span></p>
<p>而新冠病毒之所以如此可怕<span class=" fw-cl "><span>，</span></span>也是因为原始新冠病毒的 S 蛋白对 ACE2 受体的亲和力就是 SARS 的 10 倍以上<span class=" fw-cl "><span>，</span></span>而英国变异株和印度变异株的感染力还要更强<span class=" fw-cl "><span>。</span></span></p>
<p>也正因为 S 蛋白是新冠病毒入侵人体的先头部队<span class=" fw-cl "><span>，</span></span>所以大部分的疫苗研发<span class=" fw-cl "><span>，</span></span>都是针对这个 S 蛋白<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>听到这里<span class=" fw-cl "><span>，</span></span>你已经领先于市场上 90% 的投资者了<span class=" fw-cl "><span>，</span></span>不过这还不够<span class=" fw-cl "><span>。</span></span>接下来<span class=" fw-cl "><span>，</span></span>我们来看四种疫苗的原理有什么不同<span class=" fw-cl "><span>。</span></span></p>
<p><strong>先说灭活<span class=" fw-cl "><span>。</span></span>灭活疫苗是与众不同的<span class=" fw-cl "><span>，</span></span>它不是只针对 S 蛋白<span class=" fw-cl "><span>，</span></span>而是针对全病毒<span class=" fw-cl "><span>。</span></span>&nbsp;</strong></p>
<p>灭活疫苗就是把整个的新冠病毒杀死<span class=" fw-cl "><span>，</span></span>再注入到体内<span class=" fw-cl "><span>，</span></span>来引起体内的免疫反应<span class=" fw-cl "><span>，</span></span>抗原是完整的新冠病毒尸体<span class=" fw-cl "><span>。</span></span></p>
<p>免疫系统会被激活<span class=" fw-cl "><span>，</span></span>让抗体攻击抗原<span class=" fw-cl "><span>，</span></span>同时记忆 B 细胞会记下抗原的样子<span class=" fw-cl "><span>，</span></span>下次再遇到类似的题目<span class=" fw-cl "><span>，</span></span>免疫系统就能快速抢答<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p><strong>重组蛋白亚单位疫苗</strong>和灭活疫苗不同<span class=" fw-cl "><span>，</span></span>抗原不用整个病毒<span class=" fw-cl "><span>，</span></span>只用 S 蛋白的手指头 RBD<span class=" fw-cl "><span>，</span></span>毕竟没了这根手指头新冠病毒就开不了指纹锁<span class=" fw-cl "><span>。</span></span></p>
<p>而接种的人也不可能因此感染新冠肺炎<span class=" fw-cl "><span>，</span></span>安全性非常高<span class=" fw-cl "><span>。</span></span>重组合成 RBD 结构域也相对容易和便宜<span class=" fw-cl "><span>。</span></span></p>
<p>不过这种疫苗的免疫反应比较弱<span class=" fw-cl "><span>，</span></span>需要使用佐剂来刺激免疫系统<span class=" fw-cl "><span>，</span></span>而且一般来说要打三针<span class=" fw-cl "><span>。</span></span></p>
<p>也不是所有的疫苗都想着把抗原引入人体<span class=" fw-cl "><span>，</span></span>还有一些疫苗是利用患者体内的细胞产生抗原<span class=" fw-cl "><span>。</span></span> 就是我不给你定目标<span class=" fw-cl "><span>，</span></span>你自己挖坑自己跳<span class=" fw-cl "><span>。</span></span>腺病毒载体疫苗和 mRNA 疫苗都是这个套路<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>这两种疫苗都是从新冠病毒当中得到遗传信息片段<span class=" fw-cl "><span>，</span></span>也就是 mRNA 片段<span class=" fw-cl "><span>。</span></span>然后模拟病毒感染细胞的路径<span class=" fw-cl "><span>，</span></span>把这些片段让细胞复制<span class=" fw-cl "><span>。</span></span></p>
<p>可怜的细胞就是一个打工人<span class=" fw-cl "><span>，</span></span>默默地制造了很多病毒碎片成为抗原<span class=" fw-cl "><span>，</span></span>然后被免疫系统发现<span class=" fw-cl "><span>，</span></span>当场开除<span class=" fw-cl "><span>，</span></span>以儆效尤<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p><strong>腺病毒载体疫苗</strong>就是把这个 mRNA 片段装在腺病毒外壳里送进体内<span class=" fw-cl "><span>。</span></span></p>
<p>选择的 mRNA 片段翻译过来就是新冠病毒的 S 蛋白<span class=" fw-cl "><span>，</span></span>感染细胞后产生大量的 S 蛋白<span class=" fw-cl "><span>，</span></span>激活免疫反应<span class=" fw-cl "><span>。</span></span></p>
<p>而腺病毒本身是一种很弱的病毒<span class=" fw-cl "><span>，</span></span>在人体里闹不出什么问题<span class=" fw-cl "><span>。</span></span>所以就被抓来当工具人<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p>相比于腺病毒载体疫苗<span class=" fw-cl "><span>，</span></span>mRNA 疫苗要粗暴的多<span class=" fw-cl "><span>，</span></span>它直接把 mRNA 片段送进细胞<span class=" fw-cl "><span>，</span></span>然后让细胞生产抗原<span class=" fw-cl "><span>。</span></span>说起来容易<span class=" fw-cl "><span>，</span></span>但这实际上是目前最先进的第三代疫苗技术<span class=" fw-cl "><span>。</span></span></p>
<p>如果不是新冠疫情<span class=" fw-cl "><span>，</span></span>这项技术至少还要再经过数年的试验才能大规模应用<span class=" fw-cl "><span>。</span></span>但 mRNA 疫苗在抗疫当中表现突出<span class=" fw-cl "><span>，</span></span>我们下一讲会详细分析这类疫苗<span class=" fw-cl "><span>。</span></span>&nbsp;</p>
<p><strong>理解医学基础知识是发现医药投资机会的第一步<span class=" fw-cl "><span>，</span></span>理解哪些药物可以把病治好是第二步<span class=" fw-cl "><span>，</span></span>只要理解了这两步<span class=" fw-cl "><span>，</span></span>其他的都不重要<span class=" fw-cl "><span>。</span></span>&nbsp;</strong></p>
<p>默沙东的创始人 George W. Merck 说过这么一句话<span class=" fw-cl "><span>，</span></span><span class="fw-op  fw--collapsed"><span>「</span></span>我们应当永远铭记<span class=" fw-cl "><span>：</span></span>药品是为人类健康而生产<span class=" fw-cl "><span>，</span></span>不是为追求利润而制造的<span class=" fw-cl "><span>。</span></span>只要我们坚守这一信念<span class=" fw-cl "><span>，</span></span>利润必将随之而来<span class=" fw-cl fw--collapsed"><span>。</span></span><span class=" fw-cl "><span>」</span></span>&nbsp;</p>
<p>高瓴的易诺清也认为医疗健康是事关全人类发展的终极福祉<span class=" fw-cl "><span>，</span></span>医疗大健康的需求也是源源不断<span class=" fw-cl "><span>，</span></span>很难完全满足<span class=" fw-cl "><span>，</span></span>可以说也是一个供给创造需求的行业<span class=" fw-cl "><span>。</span></span></p>
<p>所以<span class=" fw-cl "><span>，</span></span>生物医药行业的核心是能否做出有利于患者的产品<span class=" fw-cl "><span>，</span></span>这是一切伟大药企的基石<span class=" fw-cl "><span>。</span></span></p>
<div class="customizeRender" data-tag="video" data-resource-id="1479477659352186881" data-is-green="false" data-add-head-tail="true" data-cover-url=""></div>
<p><br></p><p><span style="display:block;font-size: 13px;opacity:0.5;transform:translateY(-20px);">备案号:YXX1XkLPGpDfGeZ6LvFJ5YQ</span></p>
</body>
</html>